Veralto (NYSE:VLTO) Releases Q3 2025 Earnings Guidance

Key Points

• Veralto (NYSE:VLTO) has updated its Q3 2025 EPS guidance to between $0.910 and $0.950, slightly above the consensus estimate of $0.925.
• Despite a recent decrease of 0.1% in share price, Veralto’s average target price stands at $111.18 with a majority of analysts rating it as a "Hold."
• Veralto announced a quarterly dividend of $0.11 per share, representing an annual yield of 0.43%.

Veralto (NYSE:VLTO - Get Free Report) updated its third quarter 2025 earnings guidance on Monday. The company provided EPS guidance of 0.910-0.950 for the period, compared to the consensus EPS estimate of 0.925. The company issued revenue guidance of -. Veralto also updated its FY 2025 guidance to 3.720-3.800 EPS.

Analyst Ratings Changes

VLTO has been the topic of several research reports. Royal Bank Of Canada upped their price objective on Veralto from $103.00 to $104.00 and gave the stock a "sector perform" rating in a report on Thursday, May 1st. Robert W. Baird increased their target price on Veralto from $105.00 to $106.00 and gave the stock a "neutral" rating in a report on Thursday, May 1st. Stifel Nicolaus increased their price objective on shares of Veralto from $104.00 to $116.00 and gave the stock a "buy" rating in a research note on Monday, July 21st. Northcoast Research started coverage on shares of Veralto in a report on Tuesday, May 6th. They issued a "buy" rating and a $110.00 price target on the stock. Finally, Citigroup lowered their price target on shares of Veralto from $116.00 to $100.00 and set a "neutral" rating on the stock in a report on Monday, April 14th. Six investment analysts have rated the stock with a hold rating and five have given a buy rating to the company. According to MarketBeat, the stock presently has an average rating of "Hold" and a consensus target price of $111.18.

Veralto Trading Down 0.1%

Shares of NYSE:VLTO traded down $0.10 on Monday, hitting $103.18. The company had a trading volume of 2,086,402 shares, compared to its average volume of 1,043,915. The firm's 50-day simple moving average is $100.81 and its two-hundred day simple moving average is $98.45. Veralto has a 1 year low of $83.86 and a 1 year high of $115.00. The company has a quick ratio of 1.92, a current ratio of 2.19 and a debt-to-equity ratio of 1.14. The firm has a market capitalization of $25.57 billion, a price-to-earnings ratio of 28.37, a P/E/G ratio of 4.13 and a beta of 0.91.

Veralto (NYSE:VLTO - Get Free Report) last released its quarterly earnings results on Monday, July 28th. The company reported $0.93 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.89 by $0.04. Veralto had a net margin of 16.56% and a return on equity of 45.63%. The company's revenue was up 6.4% compared to the same quarter last year. During the same quarter in the prior year, the business earned $0.85 EPS. Equities analysts anticipate that Veralto will post 3.66 earnings per share for the current fiscal year.

Veralto Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, July 31st. Shareholders of record on Monday, June 30th will be issued a $0.11 dividend. The ex-dividend date of this dividend is Monday, June 30th. This represents a $0.44 dividend on an annualized basis and a yield of 0.43%. Veralto's payout ratio is currently 12.57%.

Insiders Place Their Bets

In related news, SVP Surekha Trivedi sold 848 shares of the company's stock in a transaction that occurred on Monday, June 2nd. The stock was sold at an average price of $100.55, for a total value of $85,266.40. Following the completion of the transaction, the senior vice president directly owned 8,433 shares of the company's stock, valued at $847,938.15. This represents a 9.14% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, SVP Lesley Beneteau sold 458 shares of the company's stock in a transaction that occurred on Thursday, May 15th. The stock was sold at an average price of $100.84, for a total value of $46,184.72. Following the sale, the senior vice president owned 13,571 shares of the company's stock, valued at $1,368,499.64. This trade represents a 3.26% decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders sold 45,913 shares of company stock valued at $4,339,370. Insiders own 0.36% of the company's stock.

Institutional Inflows and Outflows

Several hedge funds have recently made changes to their positions in VLTO. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its stake in shares of Veralto by 5.3% in the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 25,947 shares of the company's stock worth $2,529,000 after buying an additional 1,306 shares in the last quarter. Empowered Funds LLC grew its stake in Veralto by 20.4% in the first quarter. Empowered Funds LLC now owns 4,551 shares of the company's stock valued at $443,000 after purchasing an additional 770 shares in the last quarter. Brighton Jones LLC grew its stake in Veralto by 16.1% in the fourth quarter. Brighton Jones LLC now owns 3,459 shares of the company's stock valued at $352,000 after purchasing an additional 479 shares in the last quarter. Finally, Geneos Wealth Management Inc. grew its stake in Veralto by 102.4% in the first quarter. Geneos Wealth Management Inc. now owns 832 shares of the company's stock valued at $81,000 after purchasing an additional 421 shares in the last quarter. Institutional investors and hedge funds own 91.28% of the company's stock.

Veralto Company Profile

Veralto Corporation provides water analytics, water treatment, marking and coding, and packaging and color services worldwide. It operates through two segments, Water Quality (WQ) and Product Quality & Innovation (PQI). The WQ segment offers precision instrumentation and water treatment technologies to measure, analyze, and treat water in residential, commercial, municipal, industrial, research, and natural resource applications through the Hach, Trojan Technologies, and ChemTreat brands.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.